Skip to content

Use Of Homoeopathy In Allergic Rhinitis

Role Of Individualized Homoeopathic Medicine In Reducing Serum Immunoglobulin -E (S. Ig-E) In Cases Of Allergic Rhinitis In Paediatric Age Group Using 50 Millesimal Potency: A Prospective Pre-Test Post-Test Interventional Study - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/066588
Enrollment
40
Registered
2024-05-01
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: Individualized Homoeopathic Medicine: Indicated Individualized Homoeopathic Medicine Will Be Prescribed In 50 Millesimal Potency Through Oral Route.Frequency Of Repetition Of Doses And

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient’s Parents Willing To Give Written Informed Consent And The Patients Willing To Give Verbal Assent (Children Aged Between 6-11 Years) And Or Written Assent (Children Aged Between 12-17Years). 2.Patient In The Age Group Of 1-18 Years. 3.Patients Of All Sexes. 4.Patients With Symptoms Of Allergic Rhinitis Such As Nasal Discharge, Nasal Itching, Sneezing, Nasal Congestion. 5.Clinically Diagnosed Cases Of Allergic Rhinitis. 6.Patients Already Undergoing Conventional Treatment For Allergic Rhinitis May Be Recruited After A Washout Period Of 1 Month

Exclusion criteria

Exclusion criteria: 1.Patients Having Severe Co-Morbidities Of Allergic Rhinitis Like Asthma, Sinusitis Etc., 2.Critically Ill Patient Immuno-Compromised Patient. 3.Patients Suffering From Any Other Systemic Diseases. 4.Diagnosed Cases Of Unstable Mental Or Psychiatric Illness. 5.Patient Or Parents Of Patients Unwilling To Give Consent. 6.Patients With Substance Abuse.

Design outcomes

Primary

MeasureTime frame
Serum Immunoglobulin -E Level (S. Ig-E)Timepoint: Baseline And 6 Months

Secondary

MeasureTime frame
1. Total Nasal Symptoms Score (TNSS) 2. Modified Naranjo Criteria For Homoeopathy (MONARCH)Timepoint: 1. Baseline And After 6 Months 2. After 6 Months

Countries

India

Contacts

Public ContactDr Shishir Kumar Singh

National Institute of Homoeopathy

drshishirsinghmd@gmail.com7890321978

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026